| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $245.4M | +30.2% |
| Cost of Revenue | $55.1M | +24.9% |
| R&D Expense | $397.5M | +45.7% |
| SG&A Expense | $265.8M | +13.5% |
| Operating Income | -$457.3M | -21.9% |
| Interest Expense | $26.4M | -34.7% |
| Pre-tax Income | -$480.2M | -10.0% |
| Income Tax | $1.4M | +178.7% |
| Net Income | -$481.5M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.07B | +49.8% |
| Short-term Investments | $74.2M | — |
| Accounts Receivable | $29.7M | +22.0% |
| Inventory | $69.9M | +4.3% |
| Current Assets | $1.27B | +52.1% |
| Total Assets | $1.66B | +33.2% |
| Current Liabilities | $190.2M | +40.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$400.4M | -10.2% |
| Capital Expenditures | $9.9M | +35.5% |
| Investing Cash Flow | -$34.6M | +46.2% |
| Financing Cash Flow | $793.3M | +29.5% |
| Free Cash Flow | -$410.3M | -10.7% |
| -10.8% |
| EPS (Basic) | -$3.91 | -0.8% |
| EPS (Diluted) | -$3.91 | -0.8% |
| Long-term Debt |
| $1.15B |
| +44.3% |
| Total Liabilities | $1.57B | +88.3% |
| Stockholders' Equity | $88.0M | -78.6% |